Gene diagnosis reagent kit for detecting adults progeria syndrome
A syndrome and kit technology, which is applied in the field of kits for the detection of WRN gene 2806insA mutation, can solve problems such as not seen, and achieve the effect of simple method, low cost, and direct detection results
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2009-04-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a gene diagnosis kit for detecting adult progeria syndrome, more specifically a kit for detecting mutation of WRN gene 2806insA, the kit and method can be used for auxiliary diagnosis and new drug development of the disease, Belongs to the field of biotechnology. Background technique
[0002] Werner syndrome (Werner syndrome, WS), also known as adult progeria (Adult progeria), adult premature aging syndrome (Adult premature aging syndrome), is a rare autosomal recessive genetic disease. The clinical manifestations of WS mainly occur in connective tissue, endocrine system, immune system, nervous system, etc. Including: short stature, premature hair growth, skin fibrosis, scleroderma, cataract, subcutaneous tissue calcification, diabetes, hypothyroidism, hyperlipidemia, systemic lupus erythematosus, dementia, schizophrenia, etc. The development of WS patients is basically normal in childhood, and various symptoms begin ...
Examples
Embodiment 1
[0034] Example 1: Detection method for WRN gene 2806 heterozygous mutation
[0035] 1. Research object
[0036] Meningioma patients were collected through the neurosurgery outpatient clinic. On the premise that the patients and their family members signed the informed consent, 5-10ml blood samples were collected, and the inpatient medical record database was established to record the patient's condition, family history and contact information in detail. This study has been approved by the institutional ethics committee.
[0037] 2. Preparation of Genomic DNA
[0038] first day
[0039] 1. In the presence of the anticoagulant EDTA, centrifuge the collected 5-10ml human peripheral blood at 2500rpm for 30 minutes to remove serum;
[0040] 2. Add 0.2% NaCl solution to bring the total volume to 50 ml. Gently shake the solution 5-6 times and place it on ice for 15 minutes;
[0041] 3. Centrifuge at 2500rpm for 30 minutes to collect the precipitate;
[0042] 4. Wash with 0.2% N...
Embodiment 2
[0067] Example 2: Kit for the detection of WRN gene 2806 heterozygous mutation
[0068] 1. Components: Contains a pair of primers that can amplify the 2806 heterozygous mutation site of the WRN gene, and corresponding reagents for sequencing. The components and contents are as follows, and stored at -20°C:
[0069] 20ul 10X PCR buffer (Pharmacia),
[0070] 4ul 10mM dNTP mixture (Pharmacia),
[0071] 2ul (5unit / ul) Taq DNA polymerase (Takara),
[0072] Each 10ul (10pmol / ul) F1 (SEQ ID NO.1) and R1 (SEQ ID NO.2) primers (self-made),
[0073] 1.5ml pure water (homemade).
[0074] Two. the using method of described test kit mainly comprises the following steps:
[0075] (1) Extract the DNA of the blood sample to be tested, and use a pair of WRN2806-F and WRN2806-R primers shown in the sequence table SEQ ID No.1 and SEQ ID No.2 to carry out PCR amplification reaction;
[0076] (2) The PCR reaction product was directly sequenced after purification, and the obtained sequence was...